Zobrazeno 1 - 10
of 1 541
pro vyhledávání: '"Larssen S"'
Autor:
Sioud M; Department of Cancer Immunology, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway., Juzeniene A; Department of Radiation Biology, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway., Sæbøe-Larssen S; Department of cellular Therapy, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Jun 05; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 05.
Autor:
Maggadottir SM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Landspitali University Hospital, Reykjavik, Iceland., Dueland S; Department of Oncology, Oslo University Hospital, Oslo, Norway., Mensali N; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Hamre H; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Andresen PA; Department of Pathology, Oslo University Hospital, Oslo, Norway., Myhre MR; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Juul HV; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Bigalke I; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Lundby M; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Hønnåshagen TK; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Sæbøe-Larssen S; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Josefsen D; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Hagtvedt T; Department of Radiology, Oslo University Hospital, Oslo, Norway., Wälchli S; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Kvalheim G; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Inderberg EM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: elsin@rr-research.no.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Jun 05; Vol. 32 (6), pp. 2021-2029. Date of Electronic Publication: 2024 Apr 06.
Autor:
Tryggestad AMA; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Axcrona K; Department of Urology, Oslo University Hospital HF, Oslo, Norway.; Department of Urology, Akershus University Hospital HF, Oslo, Norway., Axcrona U; Department of Pathology, Oslo University Hospital HF, Oslo, Norway., Bigalke I; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; BioNTech IMFS GmbH, Idar-Oberstein, Germany., Brennhovd B; Department of Urology, Oslo University Hospital HF, Oslo, Norway., Inderberg EM; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Hønnåshagen TK; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Skoge LJ; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Solum G; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Saebøe-Larssen S; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Josefsen D; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Olaussen RW; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Aamdal S; Department for Clinical Research, Oslo University Hospital HF, Oslo, Norway., Skotheim RI; Department of Molecular Oncology, Oslo University Hospital HF, Oslo, Norway., Myklebust TÅ; Department of Registration, Cancer Registry Norway, Oslo, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway., Schendel DJ; Medigene Immunotherapies GmbH, Munich, Germany., Lilleby W; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Dueland S; Department for Clinical Research, Oslo University Hospital HF, Oslo, Norway., Kvalheim G; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.
Publikováno v:
The Prostate [Prostate] 2022 Feb; Vol. 82 (2), pp. 245-253. Date of Electronic Publication: 2021 Nov 11.
Publikováno v:
In Cytotherapy 2007 9(6):587-592
Autor:
Maggadóttir SM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Kvalheim G; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Wernhoff P; Department of Medical Genetics, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Sæbøe-Larssen S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Revheim ME; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Josefsen D; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Wälchli S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Helland Å; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Inderberg EM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Nov 10; Vol. 12, pp. 1031232. Date of Electronic Publication: 2022 Nov 10 (Print Publication: 2022).
Autor:
Olsthoorn, A.A., Amann, M., Bartanova, A., Clench-Aas, J., Cofala, J., Dorland, C., Guerreiro, C., Jansen, H.M.A., Henriksen, J.F., Larssen, S.
Publikováno v:
Environmental and Resource Economics, 14(3), 333-351. Springer Netherlands
Olsthoorn, A A, Amann, M, Bartanova, A, Clench-Aas, J, Cofala, J, Dorland, C, Guerreiro, C, Jansen, H M A, Henriksen, J F & Larssen, S 1999, ' Cost Benefit Analysis of European Air Quality Targets for Sulphur Dioxide, Nitrogen Dioxide and Fine Suspended Particulate Matter in Cities ', Environmental and Resource Economics, vol. 14, no. 3, pp. 333-351 . https://doi.org/10.1023/A:1008362631700
Olsthoorn, A A, Amann, M, Bartanova, A, Clench-Aas, J, Cofala, J, Dorland, C, Guerreiro, C, Jansen, H M A, Henriksen, J F & Larssen, S 1999, ' Cost Benefit Analysis of European Air Quality Targets for Sulphur Dioxide, Nitrogen Dioxide and Fine Suspended Particulate Matter in Cities ', Environmental and Resource Economics, vol. 14, no. 3, pp. 333-351 . https://doi.org/10.1023/A:1008362631700
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::339046918dd856709adbbeb8530e9576
https://doi.org/10.1023/a:1008362631700
https://doi.org/10.1023/a:1008362631700
Autor:
Boussios, Stergios1,2,3,4,5 (AUTHOR) stergiosboussios@gmail.com, Sheriff, Matin6 (AUTHOR) matin.sheriff@nhs.net, Ovsepian, Saak V.7,8 (AUTHOR) s.v.ovsepian@greenwich.ac.uk
Publikováno v:
International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13090. 20p.
Autor:
Meléndez-Vázquez, Natalie M.1 (AUTHOR) natalie.melendez2@upr.edu, Gomez-Manzano, Candelaria2 (AUTHOR) cmanzano@mdanderson.org, Godoy-Vitorino, Filipa1 (AUTHOR) filipa.godoy@upr.edu
Publikováno v:
Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1775. 23p.
Autor:
Karimi-Sani, Iman1 (AUTHOR), Molavi, Zahra2 (AUTHOR), Naderi, Samaneh1 (AUTHOR), Mirmajidi, Seyedeh-Habibeh1 (AUTHOR), Zare, Iman3 (AUTHOR), Naeimzadeh, Yasaman4 (AUTHOR), Mansouri, Atena5 (AUTHOR), Tajbakhsh, Amir6 (AUTHOR), Savardashtaki, Amir1,7 (AUTHOR) dashtaki63@gmail.com, Sahebkar, Amirhossein8,9,10 (AUTHOR) amir_saheb2000@yahoo.com
Publikováno v:
Journal of Nanobiotechnology. 10/4/2024, Vol. 22 Issue 1, p1-31. 31p.
Autor:
Sæbøe-Larssen S; Department of Cellular Therapy, Institute for Cancer Research, Oslo University Hospital-Radium, Ullernchausseen, Norway., Sioud M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Ullernchausseen, Norway. mouldy.sioud@rr-research.no.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2020; Vol. 2115, pp. 249-258.